digital health companies weight loss glp-1 Virtual startups: Pill mills or the future of obesity care? 👎 The GLP-1 startup making

GLP-1 is the same gut hormone targeted by semaglutide (Ozempic) medications it slows gastric emptying, reduces appetite, and improves insulin sensitivity

CJC-1295 no DAC acts as a GHRH analog, stimulating the GHRH-R receptor, while Ipamorelin acts as a selective agonist of the ghrelin receptor GHS-R1a

They also carry risks like bruising, infection, or a sudden drop in blood pressure

Where DSIP fits and where it does not Because the evidence is weak, the appropriate role for DSIP in any clinical conversation is narrow

Structured meal planning, hydration and mindful eating can help maintain consistency while on treatment